Solutions
AI-First Discovery Platform
Natural Compound Library
Bioactivity Prediction Models
Therapeutics
NB-A002 (DDR/HRD Cancers)
Nutraceuticals
Botanical Research Portfolio
Research Areas & Innovation Platform
Company
About Us
Investor Relations
Newsroom
Publications
Careers
Partners
Collaborations
Strategic Tech Alliances
Accelerators
Discovery & Industry Partners
Research & Academic Partners
Commercial & Distribution Partners
Contact Us
Newsroom
Company
March 23, 2026
NYB Reflects on NVIDIA GTC 2026: A Week of Discovery, Dialogue, and Momentum
NYB at GTC 2026 with valuable scientific exchange, external feedback, and cross-sector dialogue.
Read more
View All
Partnership
Case Studies
Publications
Company
Company
March 23, 2026
NYB Reflects on NVIDIA GTC 2026: A Week of Discovery, Dialogue, and Momentum
NYB at GTC 2026 with valuable scientific exchange, external feedback, and cross-sector dialogue.
Read more
Company
February 25, 2026
NYB to Exhibit at NVIDIA GTC 2026
NYB is pleased to announce that we will be exhibiting at NVIDIA GTC 2026, taking place from March 16–19, 2026.
Read more
Case Studies
February 23, 2026
How AI Discovered 3,500 Mental Wellness Compounds in 5 Months — What Took Traditional Labs Years
NYB's Vecura platform, powered by NVIDIA GPU infrastructure, is rewriting the rules of natural ingredient discovery.
Read more
No items found.
Case Studies
February 23, 2026
How AI Discovered 3,500 Mental Wellness Compounds in 5 Months — What Took Traditional Labs Years
NYB's Vecura platform, powered by NVIDIA GPU infrastructure, is rewriting the rules of natural ingredient discovery.
Read more
No items found.
Company
May 26, 2026
NYB Reflects on NVIDIA GTC 2026: A Week of Discovery, Dialogue, and Momentum
NYB at GTC 2026 with valuable scientific exchange, external feedback, and cross-sector dialogue.
Read more
Company
May 26, 2026
NYB to Exhibit at NVIDIA GTC 2026
NYB is pleased to announce that we will be exhibiting at NVIDIA GTC 2026, taking place from March 16–19, 2026.
Read more
.jpg)
